Host, parasite and drug determinants of clinical outcomes following treatment of visceral leishmaniasis: a protocol for individual participant data meta-analysis

Host, parasite and drug determinants of clinical outcomes following treatment of visceral leishmaniasis: a protocol for individual participant data meta-analysis

Introduction Visceral leishmaniasis (VL) is a parasitic disease with an estimated 30 000 new cases occurring annually. There is an observed variation in the efficacy of the current first-line therapies across different regions. Such heterogeneity could be a function of host, parasite and drug factor...

Full description

Bibliographic Details
Main Authors: James Wilson, Koert Ritmeijer, Fabiana Alves, Prabin Dahal, Kasia Stepniewska, Shyam Sundar, Philippe J Guérin, Manju Rahi, Krishna Pandey, Rishikesh Kumar, Sauman Singh-Phulgenda, Niyamat Ali Siddiqui, Abdalla Munir, Caitlin Naylor, Gemma Buck, Paritosh Malaviya
Format: Article
Language:English
Published: BMJ Publishing Group 2023-10-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/10/e074679.full

Internet

https://bmjopen.bmj.com/content/13/10/e074679.full

Similar Items